We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
5 Value Stocks to Buy Right Now as Inflation Remains Sticky
Wall Street is entering a period of renewed uncertainty as sticky inflation complicates the Federal Reserve’s stance on interest rates. U.S. inflation remains well above the central bank’s 2% target, while the prolonged conflict in the Middle East continues to create risks for energy prices and the broader economy.
With the next Fed decision approaching and September historically proving a challenging month for stocks, investors may face greater volatility ahead. This backdrop makes chasing expensive growth stocks less appealing.
Instead, investors may benefit from focusing on companies whose share prices do not fully reflect their underlying fundamentals. Value investing could offer a sensible approach in this environment, as financially solid businesses trading at reasonable valuations may provide a stronger margin of safety while giving investors room to benefit if market sentiment improves.
Value investors can consider stocks such as Herbalife Ltd., Honda Motor, Marathon Petroleum Corp. Halozyme Therapeutics and Genworth Financial, which have high earnings yield.
Understanding Earnings Yield Metric
One metric widely used by value investors to identify potentially undervalued stocks is earnings yield. Calculated by dividing a company’s annual earnings per share by its current stock price, earnings yield indicates the amount of earnings generated for every dollar invested in a stock. Generally, a higher earnings yield suggests a stock may be undervalued relative to its earnings potential, while a lower earnings yield can indicate a richer valuation.
Earnings yield also provides a useful way to compare stocks with fixed-income investments such as bonds. When a stock’s earnings yield exceeds prevailing bond yields, it may offer a more attractive return potential, making it a valuable tool for investors searching for opportunities in an uncertain market.
Here we have discussed five of the 35 stocks that qualified the screening:
Herbalife is a global nutrition company focused on helping consumers improve their health and wellness through science-based products.The Zacks Consensus Estimate for HLF’s 2026 and 2027 EPS implies year-over-year growth of 26% and 12%, respectively. While EPS estimates for the current year have remained stable over the past 30 days, they have moved up by 18 cents for 2027 over the same timeframe. Herbalife currently carries a Zacks Rank #2 and has a Value Score of A.
Hondais a leading manufacturer of automobiles and the largest producer of motorcycles in the world.The Zacks Consensus Estimate for HMC’s fiscal 2027 and 2028 EPS implies year-over-year growth of 204% and 62%, respectively. EPS estimates for the current year and the next have moved up by $1.27 and 67 cents, respectively, over the past 30 days. Honda currently sports a Zacks Rank #1 and has a Value Score of A.
Marathon Petroleum is a leading independent refiner, transporter and marketer of petroleum products. The Zacks Consensus Estimate for MPC’s 2026 EPS implies year-over-year growth of 336%. EPS estimates for the current year and the next have moved up by $3.47 and $2.29, respectively, over the past 30 days. Marathon Petroleum currently carries a Zacks Rank #2 and has a Value Score of A.
Halozyme is a biopharmaceutical company focused on the development and commercialization of novel treatments for oncology indications by targeting the tumor microenvironment. The Zacks Consensus Estimate for HALO’s 2026 and 2027 EPS implies year-over-year growth of 97% and 18%, respectively. EPS estimates for the current and next year have moved up by 23 cents and 9 cents, respectively, over the past 30 days. Halozyme currently carries a Zacks Rank #2 and has a Value Score of B.
Genworth, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. The Zacks Consensus Estimate for GNW’s 2026 and 2027 EPS implies year-over-year growth of 214% and 5%, respectively. EPS estimates for the current and next year have moved up by 66 cents and 69 cents, respectively, over the past 60 days. Genworth currently carries a Zacks Rank #2 and has a Value Score of A.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
View the Zacks #1 Rank List
Image: Bigstock
Zacks.com featured highlights Herbalife, Honda Motor, Marathon, Halozyme and Genworth
For Immediate Release
Chicago, IL – August 28, 2026 – Stocks in this week’s Herbalife Ltd. (HLF - Free Report) , Honda Motor (HMC - Free Report) , Marathon Petroleum Corp. (MPC - Free Report) , Halozyme Therapeutics (HALO - Free Report) and Genworth Financial (GNW - Free Report) .
5 Value Stocks to Buy Right Now as Inflation Remains Sticky
Wall Street is entering a period of renewed uncertainty as sticky inflation complicates the Federal Reserve’s stance on interest rates. U.S. inflation remains well above the central bank’s 2% target, while the prolonged conflict in the Middle East continues to create risks for energy prices and the broader economy.
With the next Fed decision approaching and September historically proving a challenging month for stocks, investors may face greater volatility ahead. This backdrop makes chasing expensive growth stocks less appealing.
Instead, investors may benefit from focusing on companies whose share prices do not fully reflect their underlying fundamentals. Value investing could offer a sensible approach in this environment, as financially solid businesses trading at reasonable valuations may provide a stronger margin of safety while giving investors room to benefit if market sentiment improves.
Value investors can consider stocks such as Herbalife Ltd., Honda Motor, Marathon Petroleum Corp. Halozyme Therapeutics and Genworth Financial, which have high earnings yield.
Understanding Earnings Yield Metric
One metric widely used by value investors to identify potentially undervalued stocks is earnings yield. Calculated by dividing a company’s annual earnings per share by its current stock price, earnings yield indicates the amount of earnings generated for every dollar invested in a stock. Generally, a higher earnings yield suggests a stock may be undervalued relative to its earnings potential, while a lower earnings yield can indicate a richer valuation.
Earnings yield also provides a useful way to compare stocks with fixed-income investments such as bonds. When a stock’s earnings yield exceeds prevailing bond yields, it may offer a more attractive return potential, making it a valuable tool for investors searching for opportunities in an uncertain market.
Here we have discussed five of the 35 stocks that qualified the screening:
Herbalife is a global nutrition company focused on helping consumers improve their health and wellness through science-based products.The Zacks Consensus Estimate for HLF’s 2026 and 2027 EPS implies year-over-year growth of 26% and 12%, respectively. While EPS estimates for the current year have remained stable over the past 30 days, they have moved up by 18 cents for 2027 over the same timeframe. Herbalife currently carries a Zacks Rank #2 and has a Value Score of A.
Hondais a leading manufacturer of automobiles and the largest producer of motorcycles in the world.The Zacks Consensus Estimate for HMC’s fiscal 2027 and 2028 EPS implies year-over-year growth of 204% and 62%, respectively. EPS estimates for the current year and the next have moved up by $1.27 and 67 cents, respectively, over the past 30 days. Honda currently sports a Zacks Rank #1 and has a Value Score of A.
Marathon Petroleum is a leading independent refiner, transporter and marketer of petroleum products. The Zacks Consensus Estimate for MPC’s 2026 EPS implies year-over-year growth of 336%. EPS estimates for the current year and the next have moved up by $3.47 and $2.29, respectively, over the past 30 days. Marathon Petroleum currently carries a Zacks Rank #2 and has a Value Score of A.
Halozyme is a biopharmaceutical company focused on the development and commercialization of novel treatments for oncology indications by targeting the tumor microenvironment. The Zacks Consensus Estimate for HALO’s 2026 and 2027 EPS implies year-over-year growth of 97% and 18%, respectively. EPS estimates for the current and next year have moved up by 23 cents and 9 cents, respectively, over the past 30 days. Halozyme currently carries a Zacks Rank #2 and has a Value Score of B.
Genworth, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. The Zacks Consensus Estimate for GNW’s 2026 and 2027 EPS implies year-over-year growth of 214% and 5%, respectively. EPS estimates for the current and next year have moved up by 66 cents and 69 cents, respectively, over the past 60 days. Genworth currently carries a Zacks Rank #2 and has a Value Score of A.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
For the rest of this Screen of the Week article please visit Zacks.com at:
https://www.zacks.com/stock/news/2981136/5-value-stocks-to-buy-right-now-as-inflation-remains-sticky
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.